Franklin Resources’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $250K | Sell |
108,399
-7,839
| -7% | -$18.1K | ﹤0.01% | 2629 |
|
2025
Q1 | $162K | Buy |
+116,238
| New | +$162K | ﹤0.01% | 2728 |
|
2024
Q4 | – | Sell |
-100,795
| Closed | -$201K | – | 3018 |
|
2024
Q3 | $201K | Buy |
+100,795
| New | +$201K | ﹤0.01% | 2629 |
|
2023
Q4 | – | Sell |
-810,840
| Closed | -$2.56M | – | 2713 |
|
2023
Q3 | $2.56M | Hold |
810,840
| – | – | ﹤0.01% | 1302 |
|
2023
Q2 | $536K | Hold |
810,840
| – | – | ﹤0.01% | 1931 |
|
2023
Q1 | $647K | Sell |
810,840
-229
| -0% | -$183 | ﹤0.01% | 1613 |
|
2022
Q4 | $1.83M | Hold |
811,069
| – | – | ﹤0.01% | 1386 |
|
2022
Q3 | $1.57M | Hold |
811,069
| – | – | ﹤0.01% | 1414 |
|
2022
Q2 | $3.02M | Sell |
811,069
-489,599
| -38% | -$1.82M | ﹤0.01% | 1243 |
|
2022
Q1 | $8.48M | Sell |
1,300,668
-7,865
| -0.6% | -$51.3K | ﹤0.01% | 1055 |
|
2021
Q4 | $15.2M | Sell |
1,308,533
-1,677
| -0.1% | -$19.5K | 0.01% | 958 |
|
2021
Q3 | $24.4M | Buy |
1,310,210
+4,364
| +0.3% | +$81.3K | 0.01% | 845 |
|
2021
Q2 | $27.7M | Buy |
1,305,846
+186,677
| +17% | +$3.96M | 0.01% | 791 |
|
2021
Q1 | $22.7M | Buy |
1,119,169
+319,640
| +40% | +$6.49M | 0.01% | 807 |
|
2020
Q4 | $21.2M | Sell |
799,529
-991
| -0.1% | -$26.3K | 0.01% | 801 |
|
2020
Q3 | $17.9M | Buy |
+800,520
| New | +$17.9M | 0.01% | 794 |
|